Status:
COMPLETED
NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART
Lead Sponsor:
AstraZeneca
Conditions:
Moderate/Severe Asthma
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this non-interventional study is to evaluate efficacy of Symbicort® SMART treatment in adult patients with moderate to severe asthma using ACQ scores during 6 months period
Eligibility Criteria
Inclusion
- patients eligible for entry into study are the patients diagnosed with moderate to severe asthma, that the doctors have already decided to treat with Symbicort SMART within the last month, before inclusion in this program
- All eligible patients will be included in the protocol provided they will receive detailed information in advance and will sign consent to grant access to their own data collected during this programme.
Exclusion
- All the patients who have a known hypersensitivity to Symbicort or any of its excipients will not be included in this study.
- As per valid Romanian SmPC, concomitant medication, that could result in drug interactions and could jeopardise patient safety will be carefully considered before having the patient enrolled.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
1182 Patients enrolled
Trial Details
Trial ID
NCT00785733
Start Date
November 1 2008
End Date
October 1 2009
Last Update
December 2 2010
Active Locations (44)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Alba Iulia, Romania
2
Research Site
Alexandria, Romania
3
Research Site
Arad, Romania
4
Research Site
Bacau, Romania